Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Savoy
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Savoy Pharmaceuticals is a private biotechnology company focused on the discovery and development of novel small molecule therapeutics for the treatment of cancer. The company's research centers on the Cripto-1 (CR-1) pathway, a protein that is overexpressed in many human tumors and plays a critical role in tumor growth, metastasis, and drug resistance. Their lead candidate, S-1, is designed to inhibit Cripto-1 signaling to treat various solid tumors, including breast and prostate cancer. Based in Maryland, the company was founded by experts with extensive experience in oncology research from the National Cancer Institute.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Savoy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Savoy.